文献速递肺栓塞与肺血管病

精胺促进肺血管重塑及其合成酶是肺动脉高压治疗靶点

Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension.
PubMed 文献 · Eur Respir J · 2020-11-05

该研究通过代谢组学发现特发性肺动脉高压患者血浆精胺水平升高,精胺给药可促进肺动脉平滑肌细胞增殖迁移并加重啮齿类模型肺血管重塑,抑制精胺合成酶可减轻大鼠肺动脉高压,提示精胺合成酶可能成为PAH治疗靶点。

要点

  • 特发性肺动脉高压患者血浆精胺水平高于健康对照。
  • 精胺促进肺动脉平滑肌细胞增殖迁移并加重肺血管重塑。
  • 抑制精胺合成酶可减轻野百合碱诱导的大鼠肺动脉高压。

核心结论

  • 血浆精胺促进肺血管重塑,抑制精胺合成可能成为肺动脉高压的治疗策略。

研究设计与样本

  • 研究采用功能代谢组学,评估特发性肺动脉高压患者血浆代谢谱并在另一独立队列中验证。
  • 在肺动脉平滑肌细胞和啮齿类肺动脉高压模型中检查精胺及精胺合成酶的作用。

主要发现

  • 靶向代谢组学显示特发性肺动脉高压患者血浆精胺水平高于健康对照。
  • 精胺给药促进肺动脉平滑肌细胞增殖和迁移,并加重啮齿类模型肺血管重塑。
  • 精胺的有害效应与其合成酶在病理过程中的上调相对应。
  • 体外抑制精胺合成酶可抑制血小板衍生生长因子-BB介导的肺动脉平滑肌细胞增殖。
  • 体内抑制精胺合成酶可减轻野百合碱诱导的大鼠肺动脉高压。

临床怎么用

  • 精胺合成酶可能作为肺动脉高压的潜在治疗靶点,需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pathological mechanisms of pulmonary arterial hypertension (PAH) remain largely unexplored. Effective treatment of PAH remains a challenge. The aim of this study was to discover the underlying mechanism of PAH through functional metabolomics and to help develop new strategies for prevention and treatment of PAH.Metabolomic profiling of plasma in patients with idiopathic PAH was evaluated through high-performance liquid chromatography mass spectrometry, with spermine identified to be the most significant and validated in another independent cohort. The roles of spermine and spermine synthase were examined in pulmonary arterial smooth muscle cells (PASMCs) and rodent models of pulmonary hypertension.Using targeted metabolomics, plasma spermine levels were found to be higher in patients with idiopathic PAH compared to healthy controls. Spermine administration promoted proliferation and migration of PASMCs and exacerbated vascular remodelling in rodent models of pulmonary hypertension. The spermine-mediated deteriorative effect can be attributed to a corresponding upregulation of its synthase in the pathological process. Inhibition of spermine synthase in vitro suppressed platelet-derived growth factor-BB-mediated proliferation of PASMCs, and in vivo attenuated monocrotaline-mediated pulmonary hypertension in rats.Plasma spermine promotes pulmonary vascular remodelling. Inhibiting spermine synthesis could be a therapeutic strategy for PAH.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. He YY, Yan Y, Jiang X, et al. Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension. Eur Respir J. 2020. PMID: 32513782. doi:10.1183/13993003.00522-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。